. Military Space News .
INTERN DAILY
Fire ant venom could be used for skin treatments
by Amy Wallace
Washington (UPI) Sep 11, 2017


A new study from Emory and Case Western universities found that compounds from fire ant venom could reduce skin thickening and inflammation in psoriasis.

Psoriasis is an autoimmune skin disease that is treated with topical sterioids that can cause skin thinning and bruising.

Researchers used mouse models of psoriasis to test the compound solenopsin, the main toxic component in fire ant venom, which chemically resemble ceramides, the lipid-like molecules necessary for maintaining the barrier function of skin.

The study, published today in Scientific Reports, showed solenopsin decreased skin thickness from psoriasis 30 percent compared to control groups.

"We believe that solenopsin analogs are contributing to full restoration of the barrier function in the skin," Dr. Jack Arbiser, professor of dermatology at Emory University School of Medicine, said in a press release. "Emollients can soothe the skin in psoriasis, but they are not sufficient for restoration of the barrier."

Researchers created two solenopsin analogs that resemble ceramides but can't degrade into S1P, or sphingosine-1-phosphate, that can convert ceramides into an inflammatory molecule.

Researchers found that the mice treated with solenopsin analogs also had 50 percent fewer immune cells infiltrating the skin and when the compound was applied to immune cells in a culture they decreased the cells' production of the inflammatory signal IL-22 and increased production of anti-inflammatory IL-12.

The study showed that the solenopsin analogs turned down genes that are turned up by current treatments.

"This may be compensatory and a mechanism of resistance to anti-psoriasis therapy, and it suggests that the solenopsin compounds could be used in combination with existing approaches," Arbiser said.

INTERN DAILY
Lizard venom could yield blood clot treatment breakthrough
Washington (UPI) Aug 8, 2017
Scientists have created a variety of medicines using compounds discovered in the venoms of snakes, frogs, snails, jellyfish and other animals. New research suggests lizard venoms could serve as an untapped source of medicinal compounds. Specifically, scientists at the University of Queensland believe lizard venoms could yield new treatments for blood clots. Research into lizard v ... read more

Related Links
Hospital and Medical News at InternDaily.com


Thanks for being here;
We need your help. The Space Media Network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceMediaNetwork Contributor
$5 Billed Once


credit card or paypal
SpaceMediaNetwork Monthly Supporter
$5 Billed Monthly


paypal only


Comment using your Disqus, Facebook, Google or Twitter login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

INTERN DAILY
Navy tests AN/SPY-6(V) Air and Missile Defense Radar

S. Korea, US deploy missile defence amid China protest

S.Korea, US to deploy more anti-missile defences: Seoul

S. Korea launches missile drill after North's nuclear test

INTERN DAILY
Turkey signs deal to buy Russian S-400 missile systems

Atlantic Diving Supply receives $17.6 million contract for rocket launchers

Raytheon receives $614.5M for SM-3 Block IIA ballistic missile interceptors

Lockheed completes intitial design of helicopter-mounted missile jammers

INTERN DAILY
X-37B Flies Again In First SpaceX Launch

Atlas Dynamics Introduces Fixed Wing UAV with 5-Hour Flight Time, 150 Kilometer Operational Range

Atlas Dynamics Unveils NEST Smart Protective Charging Station for Enhanced Performance of Atlas Pro Platform

Insitu receives $21M order for RQ-21A Blackjack drone parts

INTERN DAILY
82nd Airborne tests in-flight communication system for paratroopers

Spectra Airbus SlingShot Partnership Extension

Northrop awarded contract for support of Air Force communications system

Industry team demonstrates Low Cost Terminal for AEHF satellites

INTERN DAILY
Army ordering new shoulder-fired recoilless rifles

Australia developing wearable 'Fight Recorder' for soldiers

Marines use freeze-dried plasma to save foreign ally

Mobile Camouflage System displayed at DSEI 17

INTERN DAILY
L3 Technologies acquires Adaptive Methods Inc.

Trump pushes hardware to allies -- and ups pressure on N.Korea

United Technologies buying Rockwell Collins for $30 billion

Middle East conflicts boost Bulgarian arms exports

INTERN DAILY
Row in Moldova over US military drills in Ukraine

German MPs in Turkey for soldier visit amid tensions

Russia tells NATO not to worry over war games

Joint military drills begin in Ukraine as Russian war games loom

INTERN DAILY
'Nano-hashtags' could provide definite proof of Majorana particles

UMass Amherst environmental chemist flashes warning light on new nanoparticle

A more complete picture of the nano world

What the world's tiniest 'monster truck' reveals









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.